Detlev Corsepius

Detlev Corsepius

Direktor/Vorstandsmitglied bei Labor Berlin - Charité Vivantes GmbH

Health Technology

Ursprung des Netzwerks ersten Grades von Detlev Corsepius

EinheitArt der EinheitIndustrie
5
Private Company Medical Specialties 5
4
Private Company Medical Specialties 4

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Detlev Corsepius

UnternehmenSektorVerknüpfte PersonenHauptposition
Miscellaneous Commercial Services

Axel Radlach Pries

Chairman

Medical/Nursing Services

Thomas Schinecker

Chief Executive Officer

Roche Diagnostics Graz GmbH

Thomas Schinecker

Sales & Marketing

Medical Specialties

Thomas Schinecker

Chief Executive Officer

New York University College/University

Thomas Schinecker

Doctorate Degree

Biotechnology

Thomas Schinecker

Chairman

ROCHE HOLDING AG Pharmaceuticals: Major

Thomas Schinecker

Chief Executive Officer

Miscellaneous Commercial Services

Thomas Schinecker

Chief Executive Officer

Biotechnology

Thomas Schinecker

Chief Executive Officer

Hospital/Nursing Management

Andrea Grebe

Chief Executive Officer

Miscellaneous Commercial Services

Thomas Schinecker

Director/Board Member

Biotechnology

Nina Beikert

Director/Board Member

Medical Specialties

Nina Beikert

Director/Board Member

Hospital/Nursing Management

Andrea Grebe

Chief Executive Officer

Medical/Nursing Services

Andrea Grebe

Chief Executive Officer

Biotechnology

Thomas Schinecker

Corporate Officer/Principal

Statistik

International

Deutschland 7
Vereinigte Staaten 5
Schweiz 3
Belgien 3
Schweden 2

Sektoral

Health Technology 8
Health Services 6
Commercial Services 4
Consumer Services 2

Operativ

Chief Executive Officer 11
Director/Board Member 7
Chairman 4
Corporate Officer/Principal 3
Independent Dir/Board Member 2
  1. Börse
  2. Insiders
  3. Detlev Corsepius
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT